Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Accendra Health (ACH) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Accendra Health (ACH) over the last 17 years, with Q3 2025 value amounting to -$9.2 million.

  • Accendra Health's Change in Inventory fell 19859.98% to -$9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.1 million, marking a year-over-year decrease of 7412.47%. This contributed to the annual value of $26.2 million for FY2024, which is 11169.13% up from last year.
  • Accendra Health's Change in Inventory amounted to -$9.2 million in Q3 2025, which was down 19859.98% from -$119.0 million recorded in Q2 2025.
  • Over the past 5 years, Accendra Health's Change in Inventory peaked at $274.6 million during Q1 2025, and registered a low of -$173.4 million during Q4 2022.
  • In the last 5 years, Accendra Health's Change in Inventory had a median value of -$14.1 million in 2021 and averaged $2.4 million.
  • In the last 5 years, Accendra Health's Change in Inventory tumbled by 73561.62% in 2022 and then skyrocketed by 67541.23% in 2025.
  • Over the past 5 years, Accendra Health's Change in Inventory (Quarter) stood at -$20.7 million in 2021, then crashed by 735.62% to -$173.4 million in 2022, then surged by 113.1% to $22.7 million in 2023, then crashed by 567.47% to -$106.2 million in 2024, then soared by 91.31% to -$9.2 million in 2025.
  • Its last three reported values are -$9.2 million in Q3 2025, -$119.0 million for Q2 2025, and $274.6 million during Q1 2025.